Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katina Robison

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
The Lancet. Infectious Diseases|June 18, 2019
Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysisChunqing Lin, Jiri Slama, Paula Gonzalez, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)Kathleen N Moore, Michael Bookman, Jalid Sehouli, et al.
The Lancet. Infectious Diseases|June 18, 2019
Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysisChunqing Lin, Jiri Slama, Paula Gonzalez, et al.
Pageof 7